FDA Import Refusal 799-0816381-9/11/1 — Jamp Pharma Corp
The FDA refused shipment 799-0816381-9/11/1 from Jamp Pharma Corp (Canada) on Aug 30, 2022. The refused product falls under Drugs and Biologics — ASPIRIN (ANALGESIC). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Aug 30, 2022
- Country
- Canada
- Product Category
- Drugs and Biologics
- Product Code
- 60LDY05 ASPIRIN (ANALGESIC)
- Charges
- 75